193 related articles for article (PubMed ID: 33369107)
21. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
[TBL] [Abstract][Full Text] [Related]
23. [The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma].
Liu SH; Ma YM; Zhang YN; Zhao XH; Wang HY; Li B
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):64-73. PubMed ID: 36709122
[No Abstract] [Full Text] [Related]
24. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
[TBL] [Abstract][Full Text] [Related]
25. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
26. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
27. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z
Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467
[TBL] [Abstract][Full Text] [Related]
28. Protease-Activated Receptor-2 Is Associated With Adverse Outcomes in Canine Mammary Carcinoma.
Kaji K; Kaji N; Hori M; Sakai K; Yonezawa T; Maeda S
Vet Pathol; 2021 Jan; 58(1):53-62. PubMed ID: 33054598
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
Yang Y; Song KL; Chang H; Chen L
Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
[TBL] [Abstract][Full Text] [Related]
31. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
Li G; Wang X; Liu G
Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
[TBL] [Abstract][Full Text] [Related]
32. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
[TBL] [Abstract][Full Text] [Related]
33. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
[TBL] [Abstract][Full Text] [Related]
34. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
35. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.
Tu NH; Jensen DD; Anderson BM; Chen E; Jimenez-Vargas NN; Scheff NN; Inoue K; Tran HD; Dolan JC; Meek TA; Hollenberg MD; Liu CZ; Vanner SJ; Janal MN; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
J Neurosci; 2021 Jan; 41(1):193-210. PubMed ID: 33172978
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
37. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
38. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
[TBL] [Abstract][Full Text] [Related]
39. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
[TBL] [Abstract][Full Text] [Related]
40. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
